| Last Action | 01/08/20: to Banking & Insurance (S) |
|---|---|
| Title | AN ACT relating to prescription insulin. |
| Bill Documents | Introduced |
| Fiscal Impact Statement | Health Mandate |
| Bill Request Number | 1089 |
| Sponsors | P. Wheeler, R. Thomas |
| Summary of Original Version | Amend KRS 304.17A-148 to cap the cost-sharing requirements for prescription insulin at $100 per 30-day supply; amend KRS 18A.225 to require the state employee health plan to comply; EFFECTIVE January 1, 2021. |
| Index Headings of Original Version |
Diseases - Diabetes, prescription insulin drug, cost sharing, capped Drugs and Medicines - Prescription insulin drugs, cost sharing, capped Effective Dates, Delayed - Prescription insulin drugs, cost sharing, January 1, 2021 Health and Medical Services - Prescription insulin drugs, cost sharing, capped Insurance, Health - Prescription insulin drugs, cost sharing, capped Health Benefit Mandate - Prescription insulin drugs, cost sharing, capped |
| 01/07/20 |
|
|---|---|
| 01/08/20 |
|
Last updated: 10/27/2020 12:10 PM (EDT)
To receive notice when the record is updated follow @LRCTweetBot. @LRCTweetBot